ATE452911T1 - Virensicherer faktor viii mit niedrigem gehalt an höheren multimeren - Google Patents

Virensicherer faktor viii mit niedrigem gehalt an höheren multimeren

Info

Publication number
ATE452911T1
ATE452911T1 AT04805296T AT04805296T ATE452911T1 AT E452911 T1 ATE452911 T1 AT E452911T1 AT 04805296 T AT04805296 T AT 04805296T AT 04805296 T AT04805296 T AT 04805296T AT E452911 T1 ATE452911 T1 AT E452911T1
Authority
AT
Austria
Prior art keywords
factor viii
higher multimers
filtration
vwf
low content
Prior art date
Application number
AT04805296T
Other languages
English (en)
Inventor
Abdessatar Chtourou
Michel Nogre
Roland Schmitthaeusler
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34400721&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE452911(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of ATE452911T1 publication Critical patent/ATE452911T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AT04805296T 2003-10-23 2004-10-25 Virensicherer faktor viii mit niedrigem gehalt an höheren multimeren ATE452911T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312398A FR2861395B1 (fr) 2003-10-23 2003-10-23 Facteur viii viralement securise a faible teneur en multimeres superieurs
PCT/FR2004/002737 WO2005040214A1 (fr) 2003-10-23 2004-10-25 Facteur viii viralement securise a faible teneur en multimeres superieurs

Publications (1)

Publication Number Publication Date
ATE452911T1 true ATE452911T1 (de) 2010-01-15

Family

ID=34400721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805296T ATE452911T1 (de) 2003-10-23 2004-10-25 Virensicherer faktor viii mit niedrigem gehalt an höheren multimeren

Country Status (12)

Country Link
US (1) US7932355B2 (de)
EP (3) EP1675872B1 (de)
JP (2) JP4872669B2 (de)
AT (1) ATE452911T1 (de)
AU (1) AU2004283931B2 (de)
BR (1) BRPI0415743A (de)
CA (1) CA2543095C (de)
DE (1) DE602004024812D1 (de)
ES (1) ES2335893T3 (de)
FR (1) FR2861395B1 (de)
IL (3) IL175027A (de)
WO (1) WO2005040214A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
AU2008345218B2 (en) * 2007-12-28 2015-02-19 Takeda Pharmaceutical Company Limited Counter-pressure filtration of proteins
MX2010007150A (es) * 2007-12-28 2010-09-03 Baxter Int Formulaciones del factor de von-willebrand recombinante.
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
TWI508735B (zh) * 2008-10-21 2015-11-21 巴克斯特國際公司 凍乾的重組ｖｗｆ調配物
CN103608352A (zh) * 2011-06-24 2014-02-26 旭化成医疗株式会社 蛋白制剂的制造方法
JP2015515482A (ja) 2012-04-24 2015-05-28 ノヴォ ノルディスク アー／エス 血友病の治療に適する化合物
CN104804078B (zh) * 2015-05-05 2019-01-04 广东卫伦生物制药有限公司 人体血清凝血因子ⅷ中的病毒过滤方法
AU2018321131B2 (en) 2017-08-23 2024-06-13 Csl Behring Gmbh Method for virus filtration of von Willebrand Factor
CA3091348A1 (en) * 2018-02-19 2019-08-22 Bayer Healthcare Llc Modified filter membrane and method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US5522991A (en) 1994-07-20 1996-06-04 Millipore Investment Holdings Limited Cellulosic ultrafiltration membrane
EP0860444A1 (de) * 1997-02-24 1998-08-26 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) Methode zur Entfernung von Viren aus Proteinlösungen
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US6989145B2 (en) 2000-03-03 2006-01-24 Kyowa Hakko Kogyo Co., Ltd. Recombinant antibody and antibody fragment
ES2620359T3 (es) 2000-10-06 2017-06-28 Kyowa Hakko Kirin Co., Ltd. Células que producen unas composiciones de anticuerpo
HUP0600342A3 (en) 2001-10-25 2011-03-28 Genentech Inc Glycoprotein compositions
DE10211632A1 (de) 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.

Also Published As

Publication number Publication date
JP4872669B2 (ja) 2012-02-08
JP2011252016A (ja) 2011-12-15
EP2805968A1 (de) 2014-11-26
US7932355B2 (en) 2011-04-26
AU2004283931A1 (en) 2005-05-06
ES2335893T3 (es) 2010-04-06
CA2543095C (fr) 2017-07-11
DE602004024812D1 (de) 2010-02-04
EP1675872B1 (de) 2009-12-23
IL228277A (en) 2015-07-30
JP2007535487A (ja) 2007-12-06
IL175027A0 (en) 2006-08-20
IL175027A (en) 2013-10-31
FR2861395B1 (fr) 2006-02-17
CA2543095A1 (fr) 2005-05-06
IL228278A (en) 2015-07-30
BRPI0415743A (pt) 2006-12-19
EP1675872A1 (de) 2006-07-05
FR2861395A1 (fr) 2005-04-29
US20070275880A1 (en) 2007-11-29
WO2005040214A1 (fr) 2005-05-06
AU2004283931B2 (en) 2010-08-26
EP2108659A1 (de) 2009-10-14

Similar Documents

Publication Publication Date Title
IL228278A (en) Anti-coagulation factor viii, derived from plasma, is safe in terms of virus content
ES2363827T3 (es) Procedimiento para la obtención de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilización de los mismos.
KR930016109A (ko) 안정한 피브리노겐 용액
CN101677836A (zh) 用于制备纤维蛋白胶的含有浓缩纤维蛋白原的组合物和相关系统的制备方法
DE60133541D1 (de) Modifizierter faktor viii
JP2003274941A (ja) ナノろ過によってタンパク溶液からウイルスを分離する方法
DE60021098D1 (de) Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
ATE517180T1 (de) Verwendung von esterasen zur spaltung von kunststoffen
Aznar et al. Factor VIII/von Willebrand factor complex in methylene blue‐treated fresh plasma
DE69827787D1 (de) Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration
DE69729793D1 (de) Stabilisator zusammensetzung
JP4312381B2 (ja) 濾過によるウイルス的に安全な因子ｖｉｉｉ溶液の調製方法
ATE403712T1 (de) Verwendung von polymerisaten, enthaltend thermoplastische polymere als filterhilfs- und/oder stabilisierungsmittel
DE50309146D1 (de) Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
ATE421339T1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein- polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
DE602006006352D1 (de) Verfahren zur herstellung des (s)-enantiomers von omeprazol
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
NO20004071D0 (no) Karbonfiberfiltre
DE60331257D1 (de) Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle
ATE263234T1 (de) Veränderte, kleine rna-viren
Armaki et al. (D-Ala, D-Leu) enkephalin reduces the binding of GTP in hippocampal membranes
Xi et al. CLOTTING FACTOR DEPENDENCY OF PROTHROMBINASE ACTIVITY IN DICOUMAROL PLASMA. THE IMPORTANCE OF A FACTOR IX DEPENDENT PATHWAY IN EXTRINSIC COAGULATION
ATE394109T1 (de) Augentropfen mit gefiltertem lehmhaltigen wasser zur behandlung von glaukom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties